DK3386994T3 - 4,6-di-(o-thiophosphat)-inositol-1,2,3,5-tetra-o-sulfat mod c. difficile-infektion - Google Patents
4,6-di-(o-thiophosphat)-inositol-1,2,3,5-tetra-o-sulfat mod c. difficile-infektion Download PDFInfo
- Publication number
- DK3386994T3 DK3386994T3 DK16808705.4T DK16808705T DK3386994T3 DK 3386994 T3 DK3386994 T3 DK 3386994T3 DK 16808705 T DK16808705 T DK 16808705T DK 3386994 T3 DK3386994 T3 DK 3386994T3
- Authority
- DK
- Denmark
- Prior art keywords
- thiophosphate
- inositol
- tetra
- difficile infection
- sulphate
- Prior art date
Links
- 241000193163 Clostridioides difficile Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 229910021653 sulphate ion Inorganic materials 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
- C07F9/165—Esters of thiophosphoric acids
- C07F9/177—Esters of thiophosphoric acids with cycloaliphatic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15199681 | 2015-12-11 | ||
| EP16164300 | 2016-04-07 | ||
| PCT/EP2016/080545 WO2017098033A1 (en) | 2015-12-11 | 2016-12-12 | 4,6-di-(o-thiophosphate)-inositol-1,2,3,5-tetra-o-sulfate for c. difficile infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3386994T3 true DK3386994T3 (da) | 2020-01-13 |
Family
ID=57517911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16808705.4T DK3386994T3 (da) | 2015-12-11 | 2016-12-12 | 4,6-di-(o-thiophosphat)-inositol-1,2,3,5-tetra-o-sulfat mod c. difficile-infektion |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10487097B2 (da) |
| EP (1) | EP3386994B1 (da) |
| JP (1) | JP6893037B2 (da) |
| CN (1) | CN108368137B (da) |
| AU (1) | AU2016366503B2 (da) |
| CA (1) | CA3006701C (da) |
| DK (1) | DK3386994T3 (da) |
| ES (1) | ES2762984T3 (da) |
| PL (1) | PL3386994T3 (da) |
| WO (1) | WO2017098033A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021006004A2 (pt) | 2018-10-11 | 2021-06-29 | Sanifit Therapeutics S.A. | inositol fosfatos para o tratamento de calcificações ectópicas. |
| KR20210148078A (ko) | 2019-01-30 | 2021-12-07 | 사니핏 테라퓨틱스 에스.에이. | 조직 관류 증가에 사용하기 위한 이노시톨 포스페이트 화합물 |
| EP3818983A1 (en) | 2019-11-11 | 2021-05-12 | Sanifit Therapeutics S.A. | Inositol phosphate compounds for use in treating, inhibiting the progression, or preventing cardiovascular calcification |
| EP4015494A1 (en) | 2020-12-15 | 2022-06-22 | Sanifit Therapeutics S.A. | Processes for the preparation of soluble salts of inositol phosphates |
| EP4036097A1 (en) | 2021-01-29 | 2022-08-03 | Sanifit Therapeutics S.A. | Ip4-4,6 substituted derivative compounds |
| WO2024047037A1 (en) | 2022-08-30 | 2024-03-07 | ETH Zürich | Compositions for parenteral sustained release delivery of hydrophilic drugs |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8605063D0 (sv) * | 1986-11-26 | 1986-11-26 | Matti Siren | Derivatives of cyclohexane |
| US20120258936A1 (en) | 2011-04-06 | 2012-10-11 | The Board Of Regents Of The University Of Texas System | Inositol hexakisphosphate analogs and uses thereof |
| EP3521294A1 (en) * | 2011-09-29 | 2019-08-07 | ETH Zürich | Pharmaceutical compounds for use in the therapy of clostridium difficile infection |
-
2016
- 2016-12-12 US US16/060,972 patent/US10487097B2/en active Active
- 2016-12-12 CA CA3006701A patent/CA3006701C/en active Active
- 2016-12-12 PL PL16808705T patent/PL3386994T3/pl unknown
- 2016-12-12 ES ES16808705T patent/ES2762984T3/es active Active
- 2016-12-12 AU AU2016366503A patent/AU2016366503B2/en active Active
- 2016-12-12 JP JP2018529128A patent/JP6893037B2/ja active Active
- 2016-12-12 EP EP16808705.4A patent/EP3386994B1/en active Active
- 2016-12-12 CN CN201680071687.5A patent/CN108368137B/zh active Active
- 2016-12-12 WO PCT/EP2016/080545 patent/WO2017098033A1/en not_active Ceased
- 2016-12-12 DK DK16808705.4T patent/DK3386994T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3006701A1 (en) | 2017-06-15 |
| ES2762984T3 (es) | 2020-05-26 |
| CN108368137B (zh) | 2020-11-13 |
| JP2019507106A (ja) | 2019-03-14 |
| AU2016366503B2 (en) | 2021-02-04 |
| CA3006701C (en) | 2023-12-12 |
| US10487097B2 (en) | 2019-11-26 |
| PL3386994T3 (pl) | 2020-05-18 |
| AU2016366503A1 (en) | 2018-06-14 |
| EP3386994B1 (en) | 2019-12-11 |
| EP3386994A1 (en) | 2018-10-17 |
| JP6893037B2 (ja) | 2021-06-23 |
| WO2017098033A1 (en) | 2017-06-15 |
| CN108368137A (zh) | 2018-08-03 |
| US20180362554A1 (en) | 2018-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3549592T (lt) | Kompozicijos, apimančios bakterijų kamienus | |
| SI3256138T1 (sl) | Farmacevtski sestavki, ki obsegajo meloksikam | |
| DK3174868T3 (da) | Forbindelser, der er aktive mod bromodomæner | |
| LT3230281T (lt) | 1,3-tiazol-2-ilu pakeisti benzamidai | |
| DK3253762T3 (da) | 9h-pyrrolo-dipyridinderivater. | |
| EP3713931C0 (en) | 3-OXO-6-HETEROARYL-2-PHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDE | |
| CL2018000650S1 (es) | Sujetador. | |
| DK3402782T3 (da) | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decanderivater | |
| SI3662894T1 (sl) | Nanodelci, ki obsegajo takrolimus | |
| DK3386994T3 (da) | 4,6-di-(o-thiophosphat)-inositol-1,2,3,5-tetra-o-sulfat mod c. difficile-infektion | |
| BR112017023150A2 (pt) | compostos herbicidas. | |
| DK3126486T3 (da) | Immunassay, der benytter indfangningskonjugat | |
| BR112017023854A2 (pt) | estator. | |
| BR112017013156A2 (pt) | combinações de composto ativo. | |
| DK3402783T3 (da) | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater | |
| IT201600084952A1 (it) | Coglifrutta. | |
| BR112017012801A2 (pt) | combinações de composto ativo. | |
| ES1150114Y (es) | Abarcón. | |
| DK3193629T3 (da) | Formulering mod diarre, hvorved antimikrobiel resistens undgås | |
| CL2016001885A1 (es) | Bolsa hidrodegradable. | |
| DK3070964T3 (da) | Høreapparat, især hørehjælpeapparat. | |
| DK3339109T3 (da) | Låseenhed. | |
| LT3253749T (lt) | Junginiai, pasižymintys priešnavikiniu aktyvumu | |
| HRP20180585T1 (hr) | Spojevi 2,7-diazaspiro[3.5]nonana | |
| ITUB20152270A1 (it) | Macchina lava-asciuga pavimenti. |